About LifeWave

LifeWave Biomedical is developing a digital therapeutic product that improves the management of patients diagnosed with congestive heart failure (CHF), acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD) in hospital, ambulatory, and home settings.

LifeWave is a leader in a new class of non-invasive physiologic sensors using a novel, very safe, low energy RF technology. The technology enables internal organ tissue assessments and real-time monitoring that provides benefit over competing technologies. A key differentiator of the company is the ability to provide easy-to-use clinical grade products that enable continuums-of-care across settings and health states.

Senior Leadership

Steve Stephansen, CEO

Steve is responsible for the overall execution and strategic direction of LifeWave. He is a 30 year veteran of the high tech industry and has a strong record of achievement in the global commercialization of highly innovative technology products. His domain experience includes semiconductor solutions for high speed computing and signal processing, Internet video capture systems, and mobile application software. His experience in medical devices was in the development of a semiconductor device technology that was successfully licensed to a major device manufacturer for a cardiac implantable device. His functional experience has spanned marketing, sales, business development, and CEO roles of technology companies.

He was previously CEO of WebV2, Inc. and Agoura Technologies. He held the position of VP of Marketing & Sales at Information Storage Devices where he grew annual sales from $0 to $55M sales in four years, leading to successful initial and secondary public offerings. He also served in several senior marketing and sales positions at Advanced Micro Devices (AMD) early in his career and later as VP of Strategic Marketing for the $1B flash memory division.

He holds an MS in Management from the Stanford GSB, an MBA from Santa Clara University, an MSEE from Rensselaer Polytechnic Institute, and a BSEE from Lehigh University. While pursing his MS in Management at Stanford, he studied medical device development in the BioDesign program and earned a certificate for completing the Stanford Mini Med School course sequences.

Glen McLaughlin, Ph.D., Chief Technology Officer

Glen has over 20 years of product development, innovation and leadership experience. He presently serves as President and Chief Technology Officer of Zonare Medical Systems (a subsidiary of Mindray Medical). He previously served as Zonare’s Vice President of Engineering for over 12 years, having led all technology and product development. He established and managed a world class engineering team to cover all aspects of engineering development, including electrical, mechanical, software, regulatory, transducers, and imaging physics. The team consisted of 30 engineers, 15 with Ph.D.’s.

He has brought over a dozen products to market generating over $200M of revenue. Glen holds over 20 issued patents in the medical device field with over 30 pending. His passion is to bring new technologies to market that can have a positive impact on humanity. He has established research collaborations with leading academic centers both in the US and abroad.  At InCube Labs, he was instrumental to the growth of a number of medical device companies, such as Fe3 Medical, Corhythm, Neurolink, and Python Medical.
Glen holds a B.S. in Electrical Engineering for Carnegie Mellon University, a MSEE and Ph.D. from Stanford.

Dr. Eric Silfen, Chief Medical Officer (acting)

Eric Silfen, MD, MSHA, MA is a physician executive and biomedical informatician who has most recently architected and managed Medical Affairs in a Fortune 500 multinational company. As a start-up visionary for numerous medical initiatives, he possesses an engaging, participatory leadership style that creates tangible, financially viable, sustainable programs that have exceeded customer and business expectations.

Currently, Dr. Silfen serves as the principal for MedTech Analytics, LLC, a privately held firm that empowers medical affairs organizations within the medtech, biotech and pharma industries to accelerate market adoption of their company’s products, services and solutions through thought leadership, clinical innovation management, market intelligence and health knowledge management.

Most recently, Dr. Silfen was Senior Vice-President and Chief Medical Officer for Philips Healthcare where he was responsible for establishing a medical consciousness throughout the company. In this role, he worked closely with R&D groups to develop and evaluate biophysiological patient monitoring devices for hospital and remote home use. In addition, he devised methods for demonstrating the clinical and econometric evidence that commercially differentiated Philips Healthcare’s products, services and solutions, thereby supporting Philips’ commitment to personal health and well-being.

Professionally, Dr. Silfen is board-certified in emergency medicine and internal medicine. He received his medical degree and training from Georgetown University; his MSHA from the Medical College of Virginia; and, his MA in biomedical informatics from Columbia University. He has served as Senior Lecturer in the Department of Biomedical Informatics at Columbia University; as Adjunct Associate Professor in the Department of Health Administration at the Medical College of Virginia; and, as Clinical Assistant Professor in the Departments of Medicine and Emergency Medicine at Georgetown University Hospital.

He has published widely on such topics as clinical emergency diagnosis and therapy, health policy and hospital management, biomedical information systems and clinical decision support as well as actively contributes to a Huffington Post healthcare blog.